Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
See Latest ArticlesAngiotensinogen promoter variants influence gene expression in human kidney and visceral adipose tissue
Journal of Human Hypertension, 06/23/09
Sarzani R et al. - The results support the hypothesis that some human AGT promoter variants influence transcriptional activity in a tissue-specific way in humans.
R Sarzani, 06/23/09
| Novel variants in the best studied candidate gene for human hypertension, the angiotensinogen (AGT) gene, influence AGT transcption levels in visceral adipose tissue. Obesity-related blood pressure and metabolic apects may be affected. |
Today in Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
Choosing among renin-angiotensin system blockers for the management of hypertension: from pharmacology to clinical efficacy
Current Medical Research and Opinion, 11/20/09
A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial
The Lancet, 10/27/09
Comparative efficacy and safety of amlodipine/benazepril combination therapy and amlodipine monotherapy in severe hypertension
Journal of Human Hypertension, 11/10/09
Article Search
Sponsor